| 000 | 01491 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516154150.0 | ||
| 264 | 0 | _c20140220 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1488-2159 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMattheos, Nikos | |
| 245 | 0 | 0 |
_aDental implant placement with bone augmentation in a patient who received intravenous bisphosphonate treatment for osteoporosis. _h[electronic resource] |
| 260 |
_bJournal (Canadian Dental Association) _c2013 |
||
| 300 |
_ad2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAlveolar Ridge Augmentation |
| 650 | 0 | 4 | _aBisphosphonate-Associated Osteonecrosis of the Jaw |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 | _aDecision Trees |
| 650 | 0 | 4 | _aDental Abutments |
| 650 | 0 | 4 |
_aDental Implantation, Endosseous _xmethods |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aIncisor |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aZirconium |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aCaldwell, Patrick | |
| 700 | 1 | _aPetcu, Eugen B | |
| 700 | 1 | _aIvanovski, Saso | |
| 700 | 1 | _aReher, Peter | |
| 773 | 0 |
_tJournal (Canadian Dental Association) _gvol. 79 _gp. d2 |
|
| 999 |
_c22833159 _d22833159 |
||